| Period Ending | Jul 27, 2013 | Apr 27, 2013 | Jan 26, 2013 | Oct 27, 2012 |
|---|
|
Total Revenue
|
12,417,000
|
12,216,000
|
12,098,000
|
11,876,000
| | Cost of Revenue | 5,070,000 | 4,705,000 | 4,755,000 | 4,637,000 | | |
Gross Profit
|
7,347,000
|
7,511,000
|
7,343,000
|
7,239,000
| |
|
Operating Expenses |
|
Research Development | 1,517,000 | 1,542,000 | 1,452,000 | 1,431,000 |
|
Selling General and Administrative | 2,950,000 | 2,905,000 | 2,971,000 | 2,976,000 |
|
Non Recurring |
-
| 33,000 | 13,000 | 59,000 |
|
Others | 66,000 | 89,000 | 118,000 | 122,000 |
|
|
|
Total Operating Expenses |
-
| 4,569,000 | 4,554,000 | 4,588,000 | | | |
Operating Income or Loss
|
2,814,000
|
2,942,000
|
2,789,000
|
2,651,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 200,000 | 148,000 | 138,000 | 128,000 |
|
Earnings Before Interest And Taxes | 3,014,000 | 3,090,000 | 2,927,000 | 2,779,000 |
|
Interest Expense | 143,000 | 145,000 | 147,000 | 148,000 |
|
Income Before Tax | 2,871,000 | 2,945,000 | 2,780,000 | 2,631,000 |
|
Income Tax Expense | 601,000 | 467,000 | (363,000) | 539,000 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 2,270,000 | 2,478,000 | 3,143,000 | 2,092,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
2,270,000
|
2,478,000
|
3,143,000
|
2,092,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
2,270,000
|
2,478,000
|
3,143,000
|
2,092,000
|
|
0.41%